[1] Xue ShH, Lu ZhY, Zhang TCh, et al. Expression and mechanism of microRNA-940 in breast cancer [J]. Acta Anatomica Sinica, 2019, 50(1): 56-62. (in Chinese)
薛世航, 陆振一, 张同成, 等. MicroRNA-940在乳腺癌中的表达变化及作用机制[J]. 解剖学报, 2019, 50(1): 56-62.
[2] Fan L, Strasserweippl K, Li JJ, et al. Breast cancer in China[J]. Lan Oncol, 2014, 15(7): e279-e289.
[3] Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes [J]. Science, 2013, 339(6127): 1546-1558.
[4] Xue D, Cheng P, Han M, et al. An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer[J]. Oncotargets Ther, 2018, 11(1): 4755-4768.
[5] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
[6] Hong W, Dong E. The past, present and future of breast cancer research in China[J]. Cancer Lett, 2014, 351(1): 1-5.
[7] Gonzalezburgos G. GABA transporter GAT1: a crucial determinant of GABAB receptor activation in cortical circuits [J]? Adv Pharmacol, 2010, 58: 175-204.
[8] Kim K, Oh S, Park U, et al. Gene expression profiling using oligonucleotide microarray in atrophic gastritis and intestinal metaplasia[J]. Korean J Gastroenterol, 2007, 49(4): 209-224.
[9] Maolakuerban N, Azhati B, Tusong H, et al. MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1[J]. Cancer Biol Ther, 2018, 19(4): 282-291.
[10] Zhao Y, Zhou X, He Y, et al. SLC6A1-miR133a-CDX2 loop regulates SK-OV-3 ovarian cancer cell proliferation, migration and invasion[J]. Oncol Lett, 2018, 16(4): 4977-4983.
[11] Li ZH, Xiong QY, Xu L, et al. miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway[J]. Oncotarget, 2017, 8(20): 32566-32575.
[12] Gray SG, Mathiasen IS, De Meyts P. The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy [J]? Horm Metab Res, 2003, 35(11-12): 857-871.
[13] Yang Q, Ji G, Li J. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo[J]. Cancer Biol Ther, 2020, 21(3): 278-291.
[14] Sharma VR, Gupta GK, Sharma AK, et al. PI3K/Akt/mTOR intracellular pathway and breast cancer: vactors, mechanism and regulation[J]. Curr Pharm Des, 2016, 23(11): 1633-1638.
[15] Jung W, Murrell MP, Kim T. F-actin fragmentation induces distinct mechanisms of stress relaxation in the actin cytoskeleton[J]. ACS Macro Lett, 2016, 5(6): 641645.
[16] Zhao W, Kuai X, Zhou X, et al. Trop2 is a potential biomarker for the promotion of EMT in human breast cancer[J]. Oncol Rep, 2018, 40(2): 759-766.
[17] Hinz N, Jucker M. Distinct functions of AKT isoforms in breast cancer: a comprehensive review[J]. Cell Com Sig, 2019, 17(1): 1-29. |